THE PETRIZZO GROUP, INC.

Developed and executed Clever/Covert's federal advocacy strategy, positioning its proprietary opioid prevention platform that utilizies predictive analytics and clinical decision support before Congress and key Executive Branch agencies, including the Department of Veterans Affairs and HHS, to advance pilot programs, policy initiatives, and federal adoption opportunities focused on early risk identification and improved patient outcomes.